Skip to main content
. 2023 Sep 8;102(36):e34882. doi: 10.1097/MD.0000000000034882

Table 1.

Basic characteristics of included research literature.

Report Country Design H pylori methods (sampling sites) IBD methods Result Age (yr) Participant (CD/UC/IBDU) Quality assessment
Kaakoush, 2010 Australia Case-control PCR/RUT/histology (colon) Endoscopy
Histology
Radiology
main 11.4 ± 3.9 vs 10.2 ± 3.9* vs 9.1 ± 4.2 77/102 (77/0/0) 8 9
Casswall, 2010 Sweden Case-control PCR/serum/histology (liver and stomach) Endoscopy
Histology
Clinical
main NA 26/51 (4/21/1) 8 9
Hansen, 2011 United Kingdom Cohort PCR (colon) Endoscopy
Histology
Clinical
main NA 24/26 (12/8/4) 7 9
Sonnenberg, 2011 United States Case-control Histology (stomach) Endoscopy
Histology
Clinical
minor NA 26/216 (8/15/3) 9 9
Hansen, 2013 United Kingdom Cohort PCR/histology/serum (colon, stomach) Endoscopy
Histology
Radiology
minor 11.9 ± 2.9 vs 10.6 ± 3.5 44/42 (29/13/2) 7 9
Roka, 2014 Greece Case-control Histology/UBT (stomach) Endoscopy
Histology
Clinical
main 9.3 ± 4.2 vs 7.3 ± 4.4 159/1443 (66/34/59) 8 9

CD = Crohn disease, H pylori = Helicobacter pylori, IBD = inflammatory bowel disease, IBDU = inflammatory bowel disease-unclassified, NA = not available, RUT = rapid urea test, UBT = urea breath test, UC = ulcerative colitis.

*

Non-IBD with pathology.

Non-IBD with no pathology.